Vical, Inc. (NASDAQ:VICL)

CAPS Rating: 3 out of 5

The Company researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.

Recs

0
Player Avatar Biotech2010 (87.49) Submitted: 1/26/2010 8:50:26 PM : Outperform Start Price: $2.91 VICL Score: -23.07

@3.41

Featured Broker Partners


Advertisement